| Product Code: ETC12373963 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Burkina Faso continues to rely on imports for hereditary angioedema therapeutics, with key exporters in 2024 being India, France, Ghana, Morocco, and China. The market shows high concentration, as indicated by the Herfindahl-Hirschman Index (HHI). Despite a slight decline in the compound annual growth rate (CAGR) from 2020 to 2024, there was a notable growth spike from 2023 to 2024. This suggests a potential uptick in demand for hereditary angioedema therapeutics in Burkina Faso, highlighting opportunities for market expansion and strategic partnerships with leading exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Hereditary Angioedema Therapeutics Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Hereditary Angioedema Therapeutics Market - Industry Life Cycle |
3.4 Burkina Faso Hereditary Angioedema Therapeutics Market - Porter's Five Forces |
3.5 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F |
3.7 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Burkina Faso Hereditary Angioedema Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Burkina Faso Hereditary Angioedema Therapeutics Market Trends |
6 Burkina Faso Hereditary Angioedema Therapeutics Market, By Types |
6.1 Burkina Faso Hereditary Angioedema Therapeutics Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By C1-esterase inhibitor, 2021 - 2031F |
6.1.4 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Bradykinin B2 receptor antagonist, 2021 - 2031F |
6.1.5 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Kallikrein inhibitor, 2021 - 2031F |
6.1.6 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Burkina Faso Hereditary Angioedema Therapeutics Market, By End use |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Prophylaxis, 2021 - 2031F |
6.2.3 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By On-demand, 2021 - 2031F |
6.3 Burkina Faso Hereditary Angioedema Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.3 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.4 Burkina Faso Hereditary Angioedema Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
7 Burkina Faso Hereditary Angioedema Therapeutics Market Import-Export Trade Statistics |
7.1 Burkina Faso Hereditary Angioedema Therapeutics Market Export to Major Countries |
7.2 Burkina Faso Hereditary Angioedema Therapeutics Market Imports from Major Countries |
8 Burkina Faso Hereditary Angioedema Therapeutics Market Key Performance Indicators |
9 Burkina Faso Hereditary Angioedema Therapeutics Market - Opportunity Assessment |
9.1 Burkina Faso Hereditary Angioedema Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Burkina Faso Hereditary Angioedema Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F |
9.3 Burkina Faso Hereditary Angioedema Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Burkina Faso Hereditary Angioedema Therapeutics Market - Competitive Landscape |
10.1 Burkina Faso Hereditary Angioedema Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Hereditary Angioedema Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |